Functional Neuroprotective Effect of CGS 26303,a Dual ECE Inhibitor,on Ischemic-Reperfusion Spinal Cord Injury in Rats

Abstract

Endothelin-1 (ET-1) has been implicated in many neurological diseases, including subarachnoid hemorrhage (SAH) and cerebral ischemia. ET-1 is also proved to deteriorate the ischemia-reperfusion injury in many organs. Our previous studies demonstrated that the endothelin-converting enzyme (ECE) inhibitor, CGS 26303, possessed beneficial effects for the treatment of SAH and transient middle cerebral artery occlusion. In this study, we investigated the neuroprotective effect of CGS 26303 on the locomotor function and mRNA expression of heme-oxygenase-1 (HO-1) in rats subjected to a 15-min spinal cord ischemia. The results showed that pretreatment with CGS 26303 significantly preserved the locomotor function and decreased the paraplegia rate at Days 1 and 3 as compared with a saline-treated group. Furthermore, rats pretreated with CGS 26303 had a significant increase in the levels of HO-1 mRNA expression at Day 3 when compared with animals pretreated with saline after spinal cord ischemia and the sham operation group. These results suggest that CGS 26303 may have a promising neuroprotective effect in the spinal cord after ischemia-reperfusion injury, and beneficial result may be due to an adaptive mechanism involved by HO-1 overexpression.

Get full access to this article

View all access options for this article.

References

Svensson LG, Crawford ES, Hess KR, Coselli JS, Safi HJ. Experience with 1509 patients undergoing thoracoabdominal aortic operations. J Vasc Surg 17:357–368, 1993.

Kakinohana M, Taira Y, Marsala M. The effect of graded postischemic spinal cord hypothermia on neurological outcome and histopathology after transient spinal ischemia in rat. Anesthesiology 90:789–798, 1999.

Barone GW, Joob AW, Flanagan TL, Dunn CE, Kron IL. The effect of hyperemia on spinal cord function after temporary thoracic aortic occlusion. J Vasc Surg 8:535–540, 1998.

Anadol AZ, Bayram O, Dursun A, Ercan S. Role of endogenous endothelin peptides in intestinal ischemia-reperfusion injury in rats. Prostaglandins Leukot Essent Fatty Acids 59:279–283, 1998.

Kirchengast M, Munter K. Endothelin-1 and endothelin receptor antagonists in cardiovascular remodeling. Proc Soc Exp Biol Med 221: 312–325, 1999.

Hiramatsu K, Kassell NF, Goto Y, Soleau S, Lee KS. A reproducible model of reversible, focal, neocortical ischemia in Sprague-Dawley rat. Acta Neurochir (Wien) 120:66–71, 1993.

Tamion F, Richard V, Bonmarchand G, Leroy J, Lebreton JP, Thuillez C. Induction of heme-oxygenase-1 prevents the systemic responses to hemorrhagic shock. Am J Respir Crit Care Med 164:1933–1938, 2001.

Chang CZ, Yen CP, Winadi D, Wu SC, Howng SL, Lin TK, Jeng AY, Kassell NF, Kwan AL. Neuroprotective effect of CGS 26303, an endothelin-converting enzyme inhibitor, on transient middle cerebral artery occlusion in rats. J Cardiovasc Pharmacol 44:S487–S489, 2004.

Yen CP, Chen SC, Lin TK, Wu SC, Chang CY, Lue SI, Jeng AY, Kassell NF, Kwan AL. CGS 26303 upregulates mRNA expression of heme oxygenase-1 in brain tissue of rats subjected to experimental subarachnoid hemorrhage. J Cardiovasc Pharmacol 44:S474–S478, 2004.

10.

Chou AK, Yang LC, Wu PC, Wong WT, Liu GS, Chen JT, Howng SL, Tai MH. Intrathecal gene delivery of glial cell line-derived neurotrophic factor ameliorated paraplegia in rats after spinal ischemia. Brain Res Mol Brain Res 133:198–207, 2005.

11.

Kaplan-Estrin M, Jacobson SW, Jacobson JL. Neurobehavioral effects of prenatal alcohol exposure at 26 months. Neurotoxicol Teratol 21: 503–511, 1999.

12.

Uhlmann D, Witzigmann H, Senninger N, Hauss J, Spiegel HU. Protective role of an endothelin-converting enzyme inhibitor (FR901533) in hepatic ischemia/reperfusion injury. Microvasc Res 62:43–54, 2001.

13.

Patel TR, Galbraith SL, McAuley MA, Doherty AM, Graham DI, McCulloch J. Therapeutic potential of endothelin receptor antagonists in experimental stroke. J Cardiovasc Pharmacol 26:S412–S415, 1995.

14.

Morse D, Choi AM. Heme oxygenase-1: the “emerging molecule” has arrived. Am J Respir Cell Mol Biol 27:8–16, 2002.

15.

Climent B, Fernandez N, Sanz E, Sanchez A, Monge L, Garcia-Villalon AL, Dieguez G. Enhanced response of pig coronary arteries to endothelin-1 after ischemia-reperfusion. Role of endothelin receptors, nitric oxide and prostanoids. Eur J Pharmacol. 524:102–110, 2005.